New England Peptide Receives Growth Equity Investment From Ampersand Capital Partners

New England Peptide, a number one supplier of high-quality custom peptides and antibodies to the world life sciences market, nowadays proclaimed the bulk recapitalization of the corporate by punctuation mark Capital Partners. Ampersand's investment is going to be accustomed to support the company's worldwide growth initiatives, as well as supply the growth of amide synthesis capabilities to raised serve more and more world client base.....